Literature DB >> 7656231

Protein kinase C-and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein.

Y P Tsao1, C H Huang, Y K Lin, S L Chen.   

Abstract

E5a of HPV-11 is a transforming oncogene. Previously, we have shown that E5a constitutively activates the expression of protooncogene c-jun by transcriptional regulation through the AP-1 binding site in the c-jun promoter. In the present study, we used two different types of cells: the E5a transfected NIH 3T3 cells and human epidermal keratinocytes, and selectively inhibited different signal transduction pathways to investigate effects of E5a on c-jun expression. We find that protein kinase C and ras-dependent pathways are important for the c-jun induction by E5a, but not the cAMP-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656231     DOI: 10.1016/0304-3835(95)03894-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes.

Authors:  Y P Tsao; L Y Li; T C Tsai; S L Chen
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein.

Authors:  S L Chen; C H Huang; T C Tsai; K Y Lu; Y P Tsao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3'-kinase in NIH 3T3 cells.

Authors:  J Ghai; R S Ostrow; J Tolar; R C McGlennen; T D Lemke; D Tobolt; Z Liu; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

4.  Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts.

Authors:  Rahul Nath; Christine A Mant; Barbara Kell; John Cason; Jon M Bible
Journal:  Cancer Cell Int       Date:  2006-08-09       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.